Rabeprazole Impurity G is a degradation byproduct formed via demethylation of the pyrimidine ring in the parent drug, resulting in a fused pyridine-sulfinyl-pyrimidin-2-yl-thiazole core. The structure retains the 3-(4-methoxyphenyl) moiety but lacks the 1-methyl substitution, introducing a pyrimidine-2-yl linker. Key functional groups include the sulfinyl bridge, thiazole heterocycle, and methoxy aromatic substituent. This impurity serves as an HPLC reference standard for quantifying process-related degradation in rabeprazole formulations.
On RequestCC1=C(C=CN=C1CSC2=NC3=CC=CC=C3N2)OC
InChI=1S/C15H15N3OS/c1-10-13(16-8-7-14(10)19-2)9-20-15-17-11-5-3-4-6-12(11)18-15/h3-8H,9H2,1-2H3,(H,17,18)
HZNKDLUKNUEOOX-UHFFFAOYSA-N